Next Article in Journal
Microcystin-LR and Cylindrospermopsin Induced Alterations in Chromatin Organization of Plant Cells
Next Article in Special Issue
Composition and Quantitation of Microalgal Lipids by ERETIC 1H NMR Method
Previous Article in Journal
Synthesis of Marine α-Methoxylated Fatty Acid Analogs that Effectively Inhibit the Topoisomerase IB from Leishmania donovani with a Mechanism Different from that of Camptothecin
Previous Article in Special Issue
Limited Impact of 2 g/day Omega-3 Fatty Acid Ethyl Esters (Omacor®) on Plasma Lipids and Inflammatory Markers in Patients Awaiting Carotid Endarterectomy
Mar. Drugs 2013, 11(10), 3676-3688; doi:10.3390/md11103676
Article

Evaluation of the in Vitro Anti-Atherogenic Properties of Lipid Fractions of Olive Pomace, Olive Pomace Enriched Fish Feed and Gilthead Sea Bream (Sparus aurata) Fed with Olive Pomace Enriched Fish Feed

1,* , 1
, 2
, 3
, 2
 and 1
Received: 28 August 2013; in revised form: 12 September 2013 / Accepted: 13 September 2013 / Published: 30 September 2013
(This article belongs to the Special Issue Marine Fatty Acids)
View Full-Text   |   Download PDF [602 KB, uploaded 30 September 2013]   |   Browse Figures
Abstract: Given the pivotal role of Platelet-Activating-Factor (PAF) in atherosclerosis and the cardio-protective role of PAF-inhibitors derived from olive pomace, the inclusion of olive pomace in fish feed has been studied for gilthead sea bream (Sparus aurata). The aim of the current research was to elucidate the anti-atherogenic properties of specific HPLC lipid fractions obtained from olive pomace, olive pomace enriched fish feed and fish fed with the olive pomace enriched fish feed, by evaluating their in vitro biological activity against washed rabbit platelets. This in vitro study underlines that olive pomace inclusion in fish feed improves the nutritional value of both fish feed and fish possibly by enriching the marine lipid profile of gilthead sea bream (Sparus aurata) with specific bioactive lipid compounds of plant origin.
Keywords: gilthead sea bream (Sparus aurata); olive pomace; HPLC; platelet activating factor; anti-atherogenic properties gilthead sea bream (Sparus aurata); olive pomace; HPLC; platelet activating factor; anti-atherogenic properties
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Nasopoulou, C.; Gogaki, V.; Stamatakis, G.; Papaharisis, L.; Demopoulos, C.A.; Zabetakis, I. Evaluation of the in Vitro Anti-Atherogenic Properties of Lipid Fractions of Olive Pomace, Olive Pomace Enriched Fish Feed and Gilthead Sea Bream (Sparus aurata) Fed with Olive Pomace Enriched Fish Feed. Mar. Drugs 2013, 11, 3676-3688.

AMA Style

Nasopoulou C, Gogaki V, Stamatakis G, Papaharisis L, Demopoulos CA, Zabetakis I. Evaluation of the in Vitro Anti-Atherogenic Properties of Lipid Fractions of Olive Pomace, Olive Pomace Enriched Fish Feed and Gilthead Sea Bream (Sparus aurata) Fed with Olive Pomace Enriched Fish Feed. Marine Drugs. 2013; 11(10):3676-3688.

Chicago/Turabian Style

Nasopoulou, Constantina; Gogaki, Vassiliki; Stamatakis, Giorgos; Papaharisis, Leonidas; Demopoulos, Constantinos A.; Zabetakis, Ioannis. 2013. "Evaluation of the in Vitro Anti-Atherogenic Properties of Lipid Fractions of Olive Pomace, Olive Pomace Enriched Fish Feed and Gilthead Sea Bream (Sparus aurata) Fed with Olive Pomace Enriched Fish Feed." Mar. Drugs 11, no. 10: 3676-3688.


Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert